C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 409/14 (2006.01) A61K 31/472 (2006.01) A61K 31/4725 (2006.01) C07D 217/26 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2432464
The present invention provides novel compounds of Formula (I) and Formula (I(a)), or the pharmaceutically acceptable salts thereof; methods for treating neurological disorders and neurodegenerative diseases, particularly pain and migraine, comprising administering a compound of Formula (I) or Formula (I(a)); and processes for preparing compounds of Formula (I) or Formula (I(a)).
L'invention concerne de nouveaux composés correspondant à la formule (I) et à la formule (I(a)), ou bien les sels pharmaceutiquement acceptables de ces composés, ainsi que des procédés de traitement de troubles neurologiques et de maladies neurodégénératives, en particulier la douleur et la migraine, le traitement consistant à administrer un composé correspondant à la formule (I) ou à la formule (I(a)), et des procédés de préparation desdits composés de formule (I) ou de formule (I(a)).
Arnold Macklin Brian
Bleisch Thomas John
Castano Mansanet Ana Maria
Dominguez-Manzanares Esteban
Escribano Ana Maria
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Excitatory amino acid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Excitatory amino acid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excitatory amino acid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1481943